Where Oncology Pharmacists, Residents, & Technicians access Chemotherapy Drug Information, Products, & Programs
OncologyPharmacist.NET is dedicated to providing timely information, consulting services, and links for Clinical Hem/Onc/BMT Pharmacists, Residents, and Technicians, in a single location, to be used on a daily basis. Improving Patient Care through the exchange of information is our goal. Our News and Clinical Tools sections will come from practice sites throughout the world. Our Job Boards will focus on relevant positions exclusively. Our Patient Assistant Programs area will link to sites that provide drugs that are used strictly in Hematology and Oncology. New Drugs will highlight Chemotherapy and Supportive Care drugs with new indications within the last 365 days. Our hope is to integrate CMS coding and announcements in the future as well as provide an area for Hem/Onc/BMT Residents, Technicians, and Practitioners to exchange ideas. Please bookmark our site, sign up to be listed on our Advisory Board Clinicians or Speakers List, send us suggestions or guidelines to improve the site, and consider advertising in this exciting domain. OP
NewsfeedCancer / Oncology News From Medical News Today
Cancer is a condition where cells in a particular part of the body develop and reproduce uncontrollably. The cancerous cells can invade and destroy neighboring healthy tissue, including organs. There are over 200 various types of cancer, each with its method of diagnosis and treatment. In many cases, your symptoms will not be related to cancer and will be caused by other, non-cancerous health conditions.
Cognitive-behavioral therapy may help reduce memory problems in cancer surviv...
A new analysis indicates that a type of psychotherapy delivered by videoconference may help prevent some of the long-term memory issues caused by chemotherapy.
Radiation and immunotherapy combination can destroy both primary and secondar...
Radiation therapy not only kills cancer cells, but also helps to activate the immune system against their future proliferation.
Massive failure to publish trial results exposes patients to risks without pr...
Although the publication of results of clinical trials carried out in the US within 12 months of their completion has been mandatory since 2007, an astoundingly high number of Phase III radiotherapy...
Shape of tumor may affect whether cells can metastasize
Only a few cells in a cancerous tumor are able to break away and spread to other parts of the body, but the curve along the edge of the tumor may play a large role in activating these tumor-seeding...
Study links residential radon exposure to hematologic cancers in women
A new report finds a statistically-significant, positive association between high levels of residential radon and the risk of hematologic cancer (lymphoma, myeloma, and leukemia) in women.
Newsfeed display by CaRP
|Headquarters: Warwick, RI • ©2009 OncologyPharmacist.net|